UNICA IRIS Institutional Research Information System

Interim Analysis of a GITIL Prospective Multicenter Phase III Study of Early Intensified Chemotherapy with Rituximab (RHDS) and Multiple Autologous Transplantation (ASCT) versus CHOP and Rituximab Delivered Every 14 Days (R-CHOP-14) in High Risk Patients with Diffuse Large B-Cell Lymphomas (DLBCL)

CORTELAZZOS;TARELLA C;GIANNI A. M;LADETTO M;CORRADINI P;DI NICOLA M;PATTI C;MIRTO S;MAJOLINO I;BILLIO A;GUELI A;DI RAIMONDO F;GALLAMINI A;CICERI F;PIZZOLO G;BENEDETTI F;LA NASA, GIORGIO;LEONI P;SEMENZATO G;FIORITONI G;RODEGHIERO F;MARCHIOLI R;TIZIANO BARBUI T;RAMBALDI A.

2009-01-01